EUFOREA

EUFOREA Implementing optimal care for chronic respiratory diseases in everyday practice! Research | Education | Advocacy

π— π—œπ—¦π—¦π—œπ—’π—‘, π—©π—œπ—¦π—œπ—’π—‘ & π—©π—”π—Ÿπ—¨π—˜π—¦
Inspiring the Future of Respiratory Care

The European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) was founded as an international non-profit organisation under Belgian law in 2015. Since 2020, the new EUFOREA board with Professor Peter Hellings (Chairman, Belgium), Professor Ulrich Wahn (Germany) and Professor Leif Bjermer (Sweden) began to p

rofessionalize its approach to achieving its mission in close collaboration with the expanding management team and in alliance with partners striving for the same targets. Allergies and airway diseases are among the most common chronic conditions in children and throughout the life cycle. These diseases present numerous comorbidities and represent a major worldwide health problem irrespective of income. At EUFOREA, we aim to reduce the prevalence and burden of allergies and airway diseases via the implementation of optimal care through education, research, and advocacy. EUFOREA brings together specialists from the entire healthcare system to create opportunities for new innovative thinking and the development of optimal care strategies.

π—©π—œπ—¦π—œπ—’π—‘

EUFOREA is an international nonprofit organisation forming an alliance of all stakeholders from national and international organisations, institutions, and agencies with the common target to implement optimal patient care for allergies and airway diseases (asthma, chronic rhinosinusitis, rhinitis) and comorbidities. EUFOREA proposes to reduce the preventable and avoidable burden of morbidity and disability due to allergies and airway diseases by means of a multidisciplinary, practical approach with all stakeholders at national, regional, and global levels so that populations reach the highest attainable standards of health and productivity at every age and that those diseases are no longer a barrier to well-being or socio-economic development. EUFOREA is based in Europe, but its ambition is boundaryless. EUFOREA is seeking worldwide alliances to find solutions for implementing optimal patient care, including disease prevention.

π— π—œπ—¦π—¦π—œπ—’π—‘

Based on its medical scientific core competency EUFOREA offers a platform to introduce innovation and education in healthcare and to discuss progress in an effort to optimise patient care with all care providers, patients, pharmacists, general practitioners, and specialists of different focus including pulmonologists, paediatricians, allergologists and otorhinolaryngologists (Ear, Nose and Throat specialists). Information and communication of key results are targeted to the General Public Health Community. EUFOREA promotes a holistic view of patient care including multispecialty integration of care leading to better patient outcomes and more value for resources spent by healthcare systems. A special focus is laid on primary, secondary, and tertiary prevention as key actions to reduce the incidence and avoid the chronicity of diseases. Timely access to care is considered key to achieving the best outcomes and controlling healthcare spending. Value-based health care principles are vital to the mission of EUFOREA. The organisation of education on state-of-the-art patient care, including comprehensive care pathways, is a cornerstone of the activities of EUFOREA. Additionally, EUFOREA has prioritised the need to raise patient awareness as a vital component in the prevention of allergies and airway diseases. EUFOREA initiates and supports research projects to improve patient care. With its strong scientific background and a world-class network of experts, EUFOREA has ideal prerequisites to accelerate projects aimed at optimising patient care. The evaluation of different treatment options is key to monitoring the progress of optimal patient treatment. Given the novel scientific data on the prediction and prevention of allergies and airway diseases, the cost of inaction is unacceptable and therefore there is an urgent need to undertake integrated actions in Europe by joining forces in a multidisciplinary way with all stakeholders.

π—©π—”π—Ÿπ—¨π—˜π—¦

EUFOREA is a nonprofit organisation transparently and exclusively dedicated to its vision and mission. As such, EUFOREA is committed to upholding its core values of respect, academic integrity, and acting in accordance with the highest ethical norms in all cooperation, both internally and externally. As a fundament of all EUFOREA action academic independence is mandatory for all participating partners.

πŸ“’ Your voice can help shape the future of respiratory careYesterday, more than 30 patients and carers joined our latest ...
10/06/2026

πŸ“’ Your voice can help shape the future of respiratory care

Yesterday, more than 30 patients and carers joined our latest EUFOREA Patient Advisory Board meeting, representing a growing community of over 100 members across the globe.

Together, we shared experiences, discussed challenges, and explored opportunities to improve the lives of people living with airway diseases. These conversations are invaluable. The insights and ideas shared by our members help shape EUFOREA’s awareness campaigns, educational resources, and initiatives, ensuring they reflect the real needs of patients and carers.

A heartfelt thank you to everyone who participated and contributed their perspectives. Your experiences are helping to drive meaningful change in respiratory healthcare.

πŸ’™ Are you living with an airway disease, or caring for someone who is?

We would love to hear your voice. Join the EUFOREA Patient Advisory Board and become part of a community that is helping influence the future of respiratory care.

πŸ“© Become a member at: https://www.euforea.org/patient-advisory-board/

πŸ“’ EUFOREA is pleased to announce its 2026 Consensus Meeting on Updates of Pocket Guides and Algorithms in Respiratory Ca...
09/06/2026

πŸ“’ EUFOREA is pleased to announce its 2026 Consensus Meeting on Updates of Pocket Guides and Algorithms in Respiratory Care, taking place on 24 September 2026 in Amsterdam, The Netherlands.

This invitation-only meeting will bring together internationally renowned experts and healthcare professionals to advance the care of chronic respiratory diseases through collaboration, discussion, and consensus-building.

Key topics will include:
βœ” Revisiting and updating EUFOREA Pocket Guides and Algorithms in Respiratory Care
βœ” Identifying the clinical need for future Pocket Guides to support optimal patient care

The meeting will explore the latest developments in early diagnosis, innovative treatment approaches, and multidisciplinary care strategies, helping to shape practical, evidence-based guidance for physicians in their daily practice.

πŸ—“οΈ 24 September 2026
πŸ“„ Agenda coming soon

Learn more about the meeting and its objectives:
πŸ”— https://www.euforea.org/events/2026-euforea-consensus-meeting-on-updates-of-pocket-guides-and-algorithms-in-respiratory-care/

Together, we continue to develop practical guidance that supports better outcomes for patients with chronic respiratory diseases.

05/06/2026

πŸŽ™οΈ Are systemic corticosteroids an indispensable treatment or a thing of the past? Tune in to the latest ON AIR Podcast episode.

In this episode of the EUFOREA ON AIR Podcast, Dr. Diego Conti (Argentina) is joined by Dr. Sophie Scheire (Belgium) for a detailed conversation recorded in London at the Royal Society of Medicine, focusing on the release of her latest first-author publication on systemic corticosteroids in asthma and upper airway disease.

Together, they explore how this systematic review and meta-analysis expand on previous narrative work by addressing the critical question of cumulative corticosteroid exposure. The discussion highlights how evidence is shifting the perception of short-course systemic corticosteroid use in respiratory and upper airway diseases.

🎧 Listen now: https://youtu.be/21lCRqAwV8A
πŸ“š Read the paper: https://onlinelibrary.wiley.com/doi/full/10.1111/all.70332and

First author: Sophie Scheire
Last author: Valerie Hox

Co-authors:
Manon Blauwblomme, Maria Dib, Ioana Agache, Claus Bachert, Koen Boussery, Adam Chaker, Roos Colman, Stefano Del Giacco, Ibon Eguiluz-Gracia, Wytske Fokkens, Simon Gane, Peter Hellings, Claire Hopkins, Ludger Klimek, Miguel Maldonado, Juan Maza-Solano, Ralph MΓΆsges, Joaquim Mullol, Charles Pilette, Oliver Pfaar, Michael Rudenko, Mohamed H. Shamji, Sanna Toppila-Salmi, and Philippe Gevaert.

πŸš€ Registration is now open for The Future of Rhinology Symposium! Join 150 European rhinologists and a world-class inter...
04/06/2026

πŸš€ Registration is now open for The Future of Rhinology Symposium!

Join 150 European rhinologists and a world-class international faculty in Amsterdam on 25 September 2026 for a day dedicated to the future of rhinology.

πŸ—“οΈ 25 September 2026
πŸ“ Amsterdam, The Netherlands

🎟️ To register, email [email protected], and we’ll confirm your participation.

🌍 The Respiratory SUMMIT 2026 | London, UKEUFOREA is proud to bring together global leaders in respiratory medicine, pat...
03/06/2026

🌍 The Respiratory SUMMIT 2026 | London, UK

EUFOREA is proud to bring together global leaders in respiratory medicine, patient advocacy, and health policy for The Respiratory SUMMIT 2026, taking place on 19 June in London, UK.

Under the theme "Redefining CRDs as Preventable Diseases", this high-profile, invitation-only meeting will explore a paradigm shift in the prevention and management of chronic respiratory diseases (CRDs), placing prevention at the heart of patient care, from primary prevention through to quaternary prevention.

We are honoured to welcome JosΓ© Luis Castro, WHO Director-General Special Envoy for Chronic Respiratory Diseases, as Key Inspirator. The programme will feature a high-level symposium, expert panel discussion, and press conference focused on shaping the future of respiratory health.

πŸ“… 19 June 2026
πŸ“London, UK

Faculty:
Mr. JosΓ© Castro (WHO) β€’ Prof. Peter Hellings (EUFOREA) β€’ Prof. Guy Brusselle (GINA) β€’ Dr. Anju Peters (EUFOREA) β€’ Prof. Klaus Rabe (EUFOREA) β€’ Prof. Wytske Fokkens (EUFOREA) β€’ Mrs. Tonya Winders (GAAPP) β€’ Dr. Jonathan Fuld (NHS) β€’ Mr. KΓ‘roly Illy (EFA) β€’ Mrs. Sanaz Eftekhari (AAFA) β€’ Mr. Miquel Diaz (Sanofi) β€’ Prof. Philippe Gevaert (EUFOREA) β€’ Prof. Maria Torres (EAACI) β€’ Prof. Arzu Yorgancioglu (ERS) β€’ Dr. Amber Luong (ARS) β€’ Mr. Saad Alsaleh (EUFOREA) β€’ Dr. SiΓ’n Williams (IPCRG) β€’ Prof. Glenis Scadding (EUFOREA) β€’ Dr. Xander Bertels (EUFOREA)

The following companies have provided funding only for this conference through a sponsorship agreement. The companies have had no input into the content, organisation, conduct, or outputs relating to the event:

Sanofi β€’ Regeneron β€’ GSK β€’ Chiesi β€’ Lilly

πŸ“© Visit the event page for more information and subscribe for updates: https://www.euforea.org/events/the-respiratory-summit-2026/

We are excited to announce an exceptional upcoming symposium on The Future of Rhinology πŸš€Rhinology is entering a transfo...
29/05/2026

We are excited to announce an exceptional upcoming symposium on The Future of Rhinology πŸš€

Rhinology is entering a transformative era. Over recent decades, scientific progress has significantly advanced our understanding of the nose and sinuses β€” from improved management of rhinosinusitis and rhinitis, to the growing recognition of the nasal airway as a key interface with both the brain and the broader united airways system.

This landmark symposium will bring together leading European rhinologists and an internationally renowned faculty for a full day of scientific exchange, debate, and collaboration.

The event will be chaired by Professors Wytske Fokkens and Sietze Reitsma. It will feature contributions from an outstanding international faculty, including Prof. Peter Hellings, Prof. Anju Peters, Prof. Dame Valerie Lund, Prof. Manuel Bernal-Sprekelsen, Prof. Katie Whitcroft, and Prof. Ludger Klimek.

πŸ—“οΈ Friday, 25 September
πŸ“ West-Indisch Huis, Amsterdam, The Netherlands
πŸ”— Free registration coming soon! Stay tuned on www.euforea.org/events

Participants will gain:
β€’ Insight into the evolution and future direction of rhinology
β€’ Practical knowledge from world-leading experts
β€’ Continued access to recorded sessions via the EUFOREA Academy Learning Portal
β€’ Positioned for CME-accreditation

This symposium offers a unique opportunity to reflect on where the field has been, engage with current advances, and help shape where it is going next.

28/05/2026

πŸŽ₯ A new EUFOREA NEWS episode is live!

🫁 In this special edition, we look ahead to the next chapter of EUFOREA as the organisation celebrates 10 years of progress in allergy and airway disease care.

What are the priorities for the future of respiratory health? How can collaboration, innovation, education, and research continue to improve outcomes for patients worldwide?

EUFOREA welcomes 3 new board members:
Professor Klaus Rabe (Germany)
Professor Dr Anju T. Peters (USA)
Professor Joseph Han (USA)

This episode with Prof. Klaus Rabe & Prof. Anju Peters explores EUFOREA’s renewed ambitions, strengthened leadership, and continued commitment to advancing care in rhinology, allergology, and pulmonology.

πŸ‘‰ Watch the full episode on our YouTube: https://youtu.be/_BODWrbrsxc

26/05/2026

πŸŽ™οΈ ON AIR with EUFOREA – Episode #30: The Importance of Patient Education and Events like PEARL

In this episode, Prof. Peter Hellings (Belgium) is joined by Mr. Miquel Diaz (Global Public Affairs Head for Respiratory diseases at Sanofi) for an insightful conversation recorded during the PEARL Course in Brussels.

Together, they explore the growing importance of patient education and patient advocacy in modern healthcare, discussing how initiatives such as the PEARL Course help patients become active participants in their own care journey. The conversation highlights the challenges patients face when navigating increasingly complex healthcare systems, the importance of reliable educational resources, and the evolving relationship between patients and healthcare professionals through shared decision-making.

The discussion also addresses the stigma surrounding chronic respiratory diseases such as asthma, COPD, and chronic rhinosinusitis, while emphasizing the need for stronger collaboration between healthcare professionals, patient communities, and industry partners to improve long-term outcomes and empower patients through knowledge and communication.

🎧 Listen now: https://youtu.be/S8s2Q2k-Vqk

This podcast episode was supported by an unrestricted educational grant from Sanofi and Regeneron.

πŸ’¬ Did you know allergic rhinitis is more than β€œjust seasonal allergies”?While many people associate it only with sneezin...
21/05/2026

πŸ’¬ Did you know allergic rhinitis is more than β€œjust seasonal allergies”?

While many people associate it only with sneezing and a runny nose, allergic rhinitis can also have a significant impact on sleep, concentration, productivity, and overall quality of life, especially during peak allergy seasons.

🌿 Understanding the condition and recognising the signs early can help people better manage symptoms and improve their day-to-day well-being.

πŸ‘‰ Visit the Allergic Rhinitis Patient Portal to learn more: https://euforea.org/patient-portal/ar/

Better inhaler technique means better asthma control!Prof. Frederik Trinkmann attended this year edition of the ATS (Ame...
19/05/2026

Better inhaler technique means better asthma control!

Prof. Frederik Trinkmann attended this year edition of the ATS (American Thoracic Society) International Conference in Orlando, presenting how digital inhaler training can help transform patient education and respiratory care. πŸ’¨πŸ“±

It’s a major global conference focused on pulmonary, critical care, and sleep medicine taking place in Orlando from 15 to 20 May 2026.

Adres

132 Boulevard Brand Whitlock
Brussels
1200

Openingstijden

Maandag 09:00 - 17:00
Dinsdag 09:00 - 17:00
Woensdag 09:00 - 17:00
Donderdag 09:00 - 17:00
Vrijdag 09:00 - 17:00

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer EUFOREA nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Delen